SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways

European Journal of Pharmacology

Volumn 700, Issue 1-3, 2013, Pages 173-180

  Du, Guangying ^a,b   Zhu, Haibo ^a,c   Yu, Pengfei ^a,c   Wang, Hongbo ^b,c   He, Jie ^c   Ye, Liang ^c   Fu, Fenghua ^b   Zhang, Jinghai ^a   Tian, Jingwei ^b,c  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b YANTAI UNIVERSITY   (China)

^c Luye Pharma Group Ltd   (China)

Author keywords

Angiogenesis; Erythropoietin receptor; Salvianolic acid B derivative; SMND 309 ((2E) 2 6 (E) 2 carboxylvinyl 2,3 dihydroxyphenyl 3 (3,4 dihydroxyphenyl) propenoic acid); STAT3

Indexed keywords

EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN RECEPTOR; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; SALVIANOLIC ACID B; SMND 309; STAT3 PROTEIN; SULFORHODAMINE B; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; ASSAY; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EPO RECEPTOR GENE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING;

CAFFEIC ACIDS; CAPILLARIES; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873473460     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.12.013     Document Type: Article

References (29)

1. A. Anagnostou, Z. Liu, M. Steiner, K. Chin, E.S. Lee, N. Kessimian, and C.T. Noguchi Erythropoietin receptor mRNA expression in human endothelial cells Proc. Natl. Acad. Sci. U. S. A. 91 1994 3974 3978 (Pubitemid 24139555)
2. B.B. Beleslin-Cokic, V.P. Cokic, X. Yu, B.B. Weksler, A.N. Schechter, and C.T. Noguchi Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells Blood 104 2004 2073 2080 (Pubitemid 39297859)
3. M. Burger, T. Hartmann, J.A. Burger, and I. Schraufstatter KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway Oncogene 24 2005 2067 2075 (Pubitemid 40516200)
4. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
5. J. Chen, F. Wang, F.S. Lee, X. Wang, and M. Xie Separation and identification of water-soluble salvianolic acids from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography and ESI-MS analysis Talanta 69 2006 172 179 (Pubitemid 43165520)
6. Y.H. Chen, G.H. Du, and J.T. Zhang Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats Acta Pharmacol. Sin. 21 2000 463 466
7. Z. Chen, and Z.C. Han STAT3: a critical transcription activator in angiogenesis Med. Res. Rev. 28 2008 185 200 (Pubitemid 351281185)
8. L.G. Griffith, and G. Naughton Tissue engineering - current challenges and expanding opportunities Science 295 2002 1009 1014
9. A. Hoeben, B. Landuyt, M.S. Highley, H. Wildiers, A.T. Van Oosterom, and E.A. De Bruijn Vascular endothelial growth factor and angiogenesis Pharmacol. Rev. 56 2004 549 580 (Pubitemid 39658463)
10. J. Hou, J. Tian, W. Jiang, Y. Gao, and F. Fu Therapeutic effects of SMND-309, a new metabolite of salvianolic acid B, on experimental liver fibrosis Eur. J. Pharmacol. 650 2011 390 395
11. E.A. Jaffe, R.L. Nachman, C.G. Becker, and C.R. Minick Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria J. Clin. Invest. 52 1973 2745 2756
12. D. Kajdaniuk, B. Marek, W. Foltyn, and B. Kos-Kudla Vascular endothelial growth factor (VEGF) - part 1: in physiology and pathophysiology Endokrynol. Pol. 62 2011 444 455
13. I.S. Lay, C.C. Hsieh, J.H. Chiu, M.S. Shiao, W.Y. Lui, and C.W. Wu Salvianolic acid B enhances in vitro angiogenesis and improves skin flap survival in Sprague-Dawley rats J. Surg. Res. 115 2003 279 285
14. M.L. Maitland, X.J. Lou, J. Ramirez, A.A. Desai, D.S. Berlin, H.L. McLeod, R.R. Weichselbaum, M.J. Ratain, R.B. Altman, and T.E. Klein Vascular endothelial growth factor pathway Pharmacogenet. Genomics 20 2010 346 349
15. M. Nakano, K. Satoh, Y. Fukumoto, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice Circ. Res. 100 2007 662 669 (Pubitemid 46594880)
16. G. Niu, K.L. Wright, M. Huang, L. Song, E. Haura, J. Turkson, S. Zhang, T. Wang, D. Sinibaldi, D. Coppola, R. Heller, L.M. Ellis, J. Karras, J. Bromberg, D. Pardoll, R. Jove, and H. Yu Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Oncogene 21 2002 2000 2008 (Pubitemid 34270888)
17. M. Nomi, A. Atala, P.D. Coppi, and S. Soker Principals of neovascularization for tissue engineering Mol. Aspects Med. 23 2002 463 483 (Pubitemid 35254100)
18. A.K. Olsson, A. Dimberg, J. Kreuger, and L. Claesson-Welsh VEGF receptor signalling - in control of vascular function Nat. Rev. Mol. Cell Biol. 7 2006 359 371
19. K.T. Papazisis, G.D. Geromichalos, K.A. Dimitriadis, and A.H. Kortsaris Optimization of the sulforhodamine B colorimetric assay J. Immunol. Methods 208 1997 151 158 (Pubitemid 28015342)
20. D. Ribatti, M. Presta, A. Vacca, R. Ria, R. Giuliani, P. Dell'Era, B. Nico, L. Roncali, and F. Dammacco Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo Blood 93 1999 2627 2636 (Pubitemid 29181195)
21. P. Sahota, and S.I. Savitz Investigational therapies for ischemic stroke: neuroprotection and neurorecovery Neurotherapeutics 8 2011 434 451
22. M.K. Tang, D.C. Ren, J.T. Zhang, and G.H. Du Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats Phytomedicine 9 2002 405 409
23. J. Tian, F. Fu, G. Li, Y. Gao, Y. Zhang, Q. Meng, C. Li, and F. Liu Protections of SMND-309, a novel derivate of salvianolic acid B, on brain mitochondria contribute to injury amelioration in cerebral ischemia rats Phytomedicine 16 2009 726 733
24. J. Tian, F. Fu, G. Li, Y. Wang, Y. Gao, Z. Liu, and S. Zhang SMND-309, a novel derivate of salvianolic acid B, ameliorates cerebral infarction in rats: characterization and role Brain Res. 1263 2009 114 121
25. J. Tian, G. Li, S. Zhang, Y. Gao, W. Jiang, F. Fu, and Z. Liu SMND-309, a novel derivate of salvianolic acid B, attenuates apoptosis and ameliorates mitochondrial energy metabolism in rat cortical neurons Basic Clin. Pharmacol. Toxicol. 104 2009 176 184
26. Y. Yahata, Y. Shirakata, S. Tokumaru, K. Yamasaki, K. Sayama, Y. Hanakawa, M. Detmar, and K. Hashimoto Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation J. Biol. Chem. 278 2003 40026 40031 (Pubitemid 37248568)
27. J. Yang, G. Zhang, J. Tian, C. Li, W. Jiang, Y. Xing, H. Zhu, J. Hou, H. Xu, and J. Wu Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in rats Basic Clin. Pharmacol. Toxicol. 106 2010 317 323
28. L. Zhou, Z. Zuo, and M.S. Chow Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use J. Clin. Pharmacol. 45 2005 1345 1359 (Pubitemid 41643896)
29. A.H. Zisch, M.P. Lutolf, M. Ehrbar, G.P. Raeber, S.C. Rizzi, N. Davies, H. Schmokel, D. Bezuidenhout, V. Djonov, P. Zilla, and J.A. Hubbell Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth FASEB J. 17 2003 2260 2262 (Pubitemid 39561459)